Examines the cardiovascular and reproductive effects of medications which inhibit the cyclooxygenases (COX-1 and COX-2). COX-1 and COX-2 catalyze the first committed step in the synthesis of prostanoids, lipid mediators which contribute to numerous physiological and pathophysiological processes